Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Clinical trial NCT05547321 · RECRUITING
Trial details
- NCT number
- NCT05547321
- Sponsor
- Oncomatryx Biopharma S.L.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2027-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.